Fulltext

What can we learn from the Baduanjin rehabilitation as COVID-19 treatment?: A narrative review

Zhu Z 1 , Pan X 2 , Zhong F 3 , Tian J 4 , Ong MLY 1

Affiliations 

  • 1 Exercise and Sports Science Programme, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
  • 2 School of Nursing, Hunan University of Chinese Medicine, Changsha, Hunan, China
  • 3 Department of Respiratory Medicine, The First Hospital Changde City of Traditional Chinese Medicine, Changde, Hunan, China
  • 4 Department of Geriatric Medicine, Xiangya Hospital of Central South University, Changsha, Hunan, China
Nurs Open, 2023 May;10(5):2819-2830.
PMID: 36575646 DOI: 10.1002/nop2.1572

Abstract

AIM: To understand Baduanjin rehabilitation therapy in mild COVID-19 patients.

DESIGN: A narrative review.

METHODS: A literature search for COVID-19 and Baduanjin treatments was conducted on Chinese and English electronic databases: China National Knowledge Infrastructure, Wanfang Data, Embase, PubMed, Scopus, Science Direct, Ebscohost, SPORTDiscus and ProQuest.

RESULTS: Twelve studies on the Baduanjin rehabilitation for COVID-19 patients have been included. We acknowledged the considerable published research and current clinical practice using Baduanjin for COVID-19 treatment in the following areas: anxiety, depression, insomnia, lung function rehabilitation, immunity and activity endurance.

CONCLUSION: The use of Baduanjin as adjuvant therapy for COVID-19 patients' rehabilitation is still limited, therefore, more clinical studies are needed to confirm its efficacy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications